No fees unless we win.
Get a free consultation
The U.S. Food and Drug Administration announced a drug safety change for the anti-seizure drug, Potiga (ezogabine) yesterday (10-31-2013).  This new label is the most serious boxed warning the FDA gives. Risks Potiga could cause: retinal abnormalities
As reported on the FDA website (7/29/13), Psychiatric News (9/9/13 Levin) and today on ABC news (9/9/13 Jelinick), the FDA is advising the public about strengthened and updated warnings regarding the serious neurologic and psychiatric side effects associated with the antimalarial drug,
In September, a Nevada resident filed a lawsuit against Fresenius Medical Care, alleging that her mother died as a result of the dangerous side effects from the widely prescribed dry acid product used in dialysis,
The US Food and Drug Administration (FDA) has announced the recall of one lot of 1g Cefepime for Injection USP and Dextrose Injection USP (Lot H3A744, catalog 3193-11) produced by B. Braun Medical Inc. The
According to Reuters, the US Food and Drug Administration (FDA) announced last month that it would be requiring companies to include tracking codes on medical devices, allowing the agency to monitor them for safety issues or
As reported by Bloomberg News (10/11 Tirrell),  Reuters (10/11, Siddiqui) and  MedPage Today (10/11, Gever), the FDA issued a drug safety alert on Friday for Ariad’s cancer drug Iclusig (ponatinib) after one-fifth of patients in a postmarket
According to NBC News, the US Food and Drug Administration (FDA) announced earlier this month that a counterfeit dietary and male sexual enhancement product could be harmful to people with diabetes, high blood pressure, high cholesterol and
The Food and Drug Administration (FDA) has issued a safety notice saying that the fungal pill Nizoral (ketoconazole) can cause severe liver injuries and adrenal gland problems and shouldn’t be used as a first-line treatment. The FDA is
The U.S. Food and Drug Administration (FDA) announced the recall recently of Nephron Pharmaceuticals’ over-the-counter bronchodilator and inhaler device due to misleading labeling and chocking concerns. The agency said that the product’s label encourages consumers
As reported by Reuters (9/26, Clarke), the U.S. Food and Drug Administration has announced that GlaxoSmithKline Plc’s chronic lymphocytic leukemia (CLL) drug, Arzerra, and Roche Holding AG and Biogen Idec Inc’s drug, Rituxan, will now contain black
At the law firm of Zoll & Kranz, LLC, our Multidistrict Litigation (MDL) and class action attorneys work hard to gain clients their deserved rights after a serious injury from dangerous drugs, defective medical devices or consumer products. Because of our nationally recognized work in these practice areas, news outlets from across the country frequently mention our firm and its involvement in personal injury cases.
In addition to the above news sources, WTVG-TV ABC 13, SACBEE, The Washington Post, Wisconsin State Journal as well as Yahoo News have also mentioned the work of our firm in articles that are no longer available to read online.
For more information about our involvement in these as well as other drug lawsuits and litigation, call Zoll & Kranz. Our firm offers individuals a complimentary case review by simply filling out an online form located on our site. Talk with us today to learn more about how our firm may be the right fit to represent your claim.
